What is the number of analysts for BIOS stock?
The number of analysts covering BIOPLUS ACQUISITION CORP-A (BIOS) is 3.
BIOPLUS ACQUISITION CORP-A (BIOS) Forecast, Price Target & Analyst Ratings
NASDAQ:BIOS • KYG112171171
Current stock price
10.795 USD
-0.01 (-0.05%)
At close:
10.79 USD
-0.01 (-0.05%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOPLUS ACQUISITION CORP-A (BIOS).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $10.80 to mean target of $0.00, Based on 3 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
100.00%
BIOS was analyzed by 3 analysts. The buy percentage consensus is at 100. So analysts seem to be very confident about BIOS.
In the previous month the buy percentage consensus was at a similar level.
Only 3 analysts analyzed BIOS. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 935.6M -4.74% | 817.2M -12.65% | 708.9M -13.25% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 43.95M 287.57% | 39.03M -11.19% | 36.2M -7.25% | N/A | N/A | N/A | |
| EBIT YoY % growth | 22.4M 296.49% | 11.3M -49.55% | 12.6M 11.50% | N/A | N/A | N/A -680.00% | |
| Operating Margin | 2.39% | 1.38% | 1.78% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A